<DOC>
	<DOCNO>NCT01174914</DOCNO>
	<brief_summary>In vast majority infect HIV virus untreated , deterioration immune health period month year inevitably lead full-blown AIDS demise . Treatment ARV 's stop slow deterioration start certain degree progression occur save million life . The investigator ' study hypothesis effectiveness low dose FDA-approved medication , naltrexone hydrochloride , ( Low-Dose Naltrexone , LDN ) compare favorably ARV 's prevent progression HIV+ toward immune deterioration full-blown AIDS .</brief_summary>
	<brief_title>Effectiveness Study Low-Dose Naltrexone Versus ARV 's HIV+</brief_title>
	<detailed_description>The LDN ( low-dose naltrexone ) v ARV ( anti-retroviral drug ) Effectiveness Study Mali sponsor The Ojai Foundation California-USA clinical research study endorse approve Malian Government . Naltrexone hydrochloride generic , FDA-approved since 1998 drug , opioid antagonist clinically show immune enhancing/modulating quality low dosage may offer alternative ARV drug effective , non-toxic , easily available , inexpensive , simple once-daily bedtime administration . LDN capsule must create compound pharmacist get ultra-small dos . Due toxicity current ARV drug need special medical management young HIV infect child largely neglect particularly develop country ; LDN also make available transdermal cream infant child HIV infect .</detailed_description>
	<mesh_term>HIV Seropositivity</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>HIV1 infect CD4 count 350 ( arm 1/group 1 ) CD4 count 200 ARV 's ( arm 2,3/groups 2,3 ) Age 18 &amp; 60 Males female Exclusion criterion : HIV1 seronegative HIV2 infect CD4 count low 200 patient age 18 Those refuse study Pregnant breastfeed woman Patients immunosuppressor therapy Those renal hepatic dysfunction Malaria tuberculosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>